Fundz

Biophytis Sa reported raising $2.6 Million in an initial SEC Form D filing, from an offering of $2.6 Million

PRIVATESep 23, 2026

Amount Raised

$2.6 Million

$2.6 Million sold, per SEC Form D (first sale Sep 15, 2026)

Round Type

Seed

ParisBiotechnologyHealth CareTherapeutics

Quick answer

Biophytis raised $2.6 Million in a Seed round, dated September 15, 2026. Biophytis is based in Paris, Ile-de-France, France.

How much did Biophytis raise?
Biophytis raised $2.6 Million in a Seed round on September 15, 2026.
What does Biophytis do?
Biophytis SA (www.biophytis.com), founded in 2006, develops drug candidates targeting diseases of aging.
Where is Biophytis based and how big is it?
Biophytis is based in Paris, Ile-de-France, France. Fundz records about 23 employees.
Who are the decision-makers at Biophytis?
Fundz holds 1 contact at Biophytis. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Biophytis that raised within 45 days of this round, from Fundz verified event records.

  • Setara Biosciences raised $90M (Series A) on October 30, 2026.
  • StimCardio raised $30M (Series A) on October 29, 2026.
  • Sonocare Lab raised an undisclosed amount (Seed) on October 29, 2026.
  • Tivic raised $85M (Series B) on October 27, 2026.
  • VolitionRx raised $2.4M (Convertible Note) on October 27, 2026.
  • Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.

Who to call at Biophytis, and when

A new round usually means Biophytis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Biophytis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Biophytis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Biophytis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Biophytis

Location

Paris, Ile-de-France, France

About

Biophytis SA (www.biophytis.com), founded in 2006, develops drug candidates targeting diseases of aging. Using its technology and know-how, Biophytis has begun clinical development of innovative therapeutics to restore the muscular and visual functions in diseases with significant unmet medical needs. Specifically, the company is advancing two proprietary drug candidates into mid-stage clinical testing this year: Sarconeos (BIO101) to treat sarcopenic obesity and Macuneos (BIO201) to treat dry age-related macular degeneration (AMD). The business model of BIOPHYTIS is to ensure the conduct of the project until clinical activity in the patient is proven, then to license the technologies in order to continue the development in partnership with a pharmaceutical laboratory. The company was founded in partnership with researchers at the UPMC (Pierre and Marie Curie University) and collaborates with scientists at the Institute of Myology, and the Vision Institute

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Biophytis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Biophytis's next move

See what Strategic adds

Biophytis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.